Societal costs of insomnia

Sleep Medicine Reviews

Volumn 14, Issue 6, 2010, Pages 379-389

  Leger D ^a   Bayon, Virginie ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Absenteeism; Costs; Insomnia; Quality of life; Work limitation

Indexed keywords

ABSENTEEISM; ACCIDENT; ANXIETY DISORDER; CAREER; COMORBIDITY; COPING BEHAVIOR; COST OF ILLNESS; DEMOGRAPHY; DEPRESSION; DRUG COST; HEALTH CARE ACCESS; HEALTH CARE UTILIZATION; HUMAN; INSOMNIA; JOB CHARACTERISTICS; JOB PERFORMANCE; PREVALENCE; QUALITY OF LIFE; REVIEW; SOCIAL ASPECT;

ABSENTEEISM; ANXIETY; COMORBIDITY; COST OF ILLNESS; DEPRESSION; EMPLOYMENT; HEALTH CARE COSTS; HUMANS; OCCUPATIONAL DISEASES; QUALITY OF LIFE; RISK FACTORS; SICK LEAVE; SLEEP DEPRIVATION; SLEEP INITIATION AND MAINTENANCE DISORDERS; SOCIAL ENVIRONMENT;

EID: 77957877712     PISSN: 10870792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smrv.2010.01.003     Document Type: Review

References (94)

1. Ohayon M.M. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 2002, 6:97-111.
2. Soldatos C.R., Allaert F.A., Ohta T., Dikeos D.G. How do individuals sleep around the world? Results from a single-day survey in ten countries. Sleep Med 2005, 6:5-13.
3. Léger D., Poursain B., Neubauer D., Uchiyama M. An international survey of sleeping problems in the general population. Curr Med Res Opin 2008, 24:307-317.
4. Alattar M., Harrington J.J., Mitchell C.M., Sloane P. Sleep problems in primary care: a North Carolina Family Practice Research Network (NC-FP-RN) study. J Am Board Fam Med 2007, 20:365-374.
5. Roth T., Hajak G., Ustun T.B. Consensus for the pharmacological management of insomnia in the new millenium. Int J Clin Pract 2001, 55:42-52.
6. World Health Organization Insomnia: an international consensus conference report. Versailles, 13-15 October 1996 1998, WHO Publications, 55 p. MSA/MDN/98.2.
7. Edinger J.D., Bonnet M.H., Bootzin R.R., Doghramji K., Dorsey C.M., Espie C.A., et al. American Academy of Sleep Medicine Work Group. Derivation of research diagnostic criteria for insomnia: report of an American Academy of Sleep Medicine Work Group. Sleep 2004, 27:1567-1596.
8. Buysse D.J. Diagnosis and assessment of sleep and circadian rhythm disorders. J Psychiatr Pract 2005, 11:102-115.
9. Kupfer D.J., Reynolds C.F. Management of insomnia. N Eng J Med 1997, 336:341-346.
10. Schenck C.H., Mahowald M.W., Sack R.L. Assessment and management of insomnia. JAMA 2003, 19:2475-2479.
11. Ohayon M.M., Smirne S. Prevalence and consequences of insomnia disorders in the general population of Italy. Sleep Med 2002, 3:115-120.
12. Leger D., Guilleminault C., Dreyfus J.P., Delahaye C., Paillard M. Prevalence of insomnia in a survey of 12,778 adults in France. J Sleep Res 2000, 9:35-42.
13. Kim K., Uchiyama M., Okawa M., Liu X., Ogihara R. An epidemiological study of insomnia among the Japanese general population. Sleep 2000, 23:41-47.
14. National Sleep Foundation (NSF) Sleep in America 2004, Gallup Organization. http://www.sleepfoundation.org.
15. Ohayon M.M. Prevalence and correlates of non-restorative sleep complaints. Arch Intern Med 2005, 165:35-41.
16. Ohayon M.M., Lemoine P. Daytime consequences of insomnia complaints in the French general population. L'Encephale 2004, 30:222-227.
17. Nakata A., Haratani T., Takahashi M., Kawakami N., Arito H., Kobayashi F., et al. Job stress, social support, and prevalence of insomnia in a population of Japanese daytime workers. Soc Sci Med 2004, 59:1719-1730.
18. Doi Y., Minowa M., Tango T. Impact and correlates of poor sleep quality in Japanese white- collar employees. Sleep 2003, 26:467-471.
19. Gellis L.A., Lichstein K.L., Scarinci I.C., Durrence H.H., Taylor D.J., Bush A.J., et al. Socioeconomic status and insomnia. J Abnorm Psychol 2005, 114:111-118.
20. National Sleep Foundation (NSF) Sleep in America 1991, Gallup Organization, Princeton, NJ.
21. Leger D., Guilleminault C., Bader G., Levy E., Paillard M. Medical and socio-professional impact of insomnia. Sleep 2002, 25:625-629.
22. Johnson E.O., Roehrs T., Roth T., Breslau N. Epidemiology of alcohol and medication as aid sleep in early adulthood. Sleep 1998, 21:178-186.
23. Aikens J.E., Rouse M.E. Help-seeking for insomnia among adult patients in primary care. J Am Board Fam Pract 2005, 18:257-261.
24. Pires M.L., Benedito-Silva A.A., Mello M.T., Pompeia Sdel G., Tufik S. Sleep habits and complaints of adults in the city of São Paulo, Brazil, in 1987 and 1995. Braz J Med Biol Res 2007, 40:1505-1515.
25. Hatoum H.T., Kania C.M., Kong S.X., Wong J.M., Mendelson W.B. Prevalence of insomnia: a survey of the enrolees at five managed care organizations. Am J Manag Care 1998, 4:79-86.
26. Wittchen H.U., Krause P., Hofler M., Pittrow D., Winter S., Spiegel B., et al. NISAS-2000: the " nationwide insomnia screening and awareness study" Prevalence and interventions in primary care. Fortschr Med Orig 2001, 119:9-19.
27. Sivertsen B., Krokstad S., Mykletun A., Overland S. Insomnia symptoms and use of health care services and medications: the HUNT-2 study. Behav Sleep Med 2009, 7:210-222.
28. Buysse D.J., Angst J., Gamma A., Ajdacic V., Eich D., Rössler W. Prevalence, course, and comorbidity of insomnia and depression in young adults. Sleep 2008, 31:473-480.
29. Roth T., Jaeger S., Jin R., Kalsekar A., Stang P.E., Kessler R.C. Sleep problems, comorbid mental disorders, and role functioning in the national comorbidity survey replication. Biol Psychiatry 2006, 60:1364-1371.
30. Sivertsen B., Krokstad S., Overland S., Mykletun A. The epidemiology of insomnia: associations with physical and mental health. The HUNT-2 study. J Psychosom Res 2009, 67:109-116.
31. Gjesdal S., Ringdal P.R., Haug K., Gunnar Mæland J. Long-term sickness absence and disability pension with psychiatric diagnoses: a population-based cohort study. Nord J Psychiatry 2008, 14:1-8.
32. Kessler R.C., Heeringa S., Lakoma M.D., Petukhova M., Rupp A.E., Schoenbaum M., et al. Individual and societal effects of mental disorders on earnings in the United States: results from the national comorbidity survey replication. Am J Psychiatry 2008, 165:703-711.
33. Wang P.S., Aguilar-Gaxiola S., Alonso J., Angermeyer M.C., Borges G., Bromet E.J., et al. Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys. Lancet 2007, 370:841-850.
34. Overland S., Glozier N., Sivertsen B., Stewart R., Neckelman D., Krokstad S., et al. A comparison of insomnia and depression as predictors of disability pension: the HUNT Study. Sleep 2008, 31:875-880.
35. Stepanski E., Zorick F., Roehrs T., Young D., Roth T. Daytime alertness in patients with chronic insomnia compared with asymptomatic control subjects. Sleep 1988, 11:54-60.
36. Riedel B.W., Lichstein K.L. Insomnia and daytime functioning. Sleep Med Rev 2000, 4:277-298.
37. Schneider-Helmert D. Twenty four hour sleep/wake function and personality patterns in chronic insomniacs and healthy controls. Sleep 1987, 11:54-60.
38. Manocchia M., Keller S., Ware J.E. Sleep problems, health-related quality of life, work functioning and health care utilization among the chronically ill. Qual Life Res 2001, 10:331-345.
39. Lerner D., Henke R.M. What does research tell us about depression, job performance, and work productivity?. J Occup Environ Med 2008, 50:401-410.
40. Leigh P. Employee and job attributes and predictors of absenteeism in a national sample of workers: the importance of health and dangerous working conditions. Soc Sci Med 1991, 33:127-131.
41. Lavie P. Sleep habits and sleep disturbances in industrial workers in Israel: main findings and some characteristics of workers complaining of daytime sleepiness. Sleep 1981, 4:147-158.
42. Leger D., Massuel M.A., Metlaine A. SISYPHE Study Group. Professional correlates of insomnia. Sleep 2006, 29:171-178.
43. Philip P., Leger D., Taillard J., Quera-Salva M.A., Niedhammer I., Mosqueda J.G., et al. Insomniac complaints interfere with quality of life but not with absenteeism: respective role of depressive and organic comorbidity. Sleep Med 2006, 7:585-591.
44. Sivertsen B., Overland S., Bjorvatn B., Maeland J.G., Mykletun A. Does insomnia predict sick leave? The Hordaland Health Study. J Psychosom Res 2009, 66:67-74.
45. Akerstedt T., Keccklund G., Alfredsson L., Selen J. at al. Predicting long-term sickness absence from sleep and fatigue. J Sleep Res 2007, 16:341-345.
46. Daley M., Morin C.M., Leblanc M., Grégoire J.P., Savard J., Baillargeon L. Insomnia and its relationship to health-care utilization, work absenteeism, productivity and accidents. Sleep Med 2009, 10:427-438.
47. Johnson L.C., Spinweber C.L., Gomez S.A., Matteson L.T. Daytime sleepiness, performance, mood, nocturnal sleep: the effect of benzodiazepine and caffeine on their relationship. Sleep 1990, 13:121-135.
48. Daley M.E., LeBlanc M., Morin C.M. The impact of insomnia on absenteeism, productivity and accidents rate. Sleep 2005, 28:A247.
49. Bolge S.C., Doan J.F., Kannan H., Baran R.W. Association of insomnia with quality of life, work productivity, and activity impairment. Qual Life Res 2009, 18:415-422.
50. Sivertsen B., Øverland S., Pallesen S., Bjorvatn B., Nordhus I.H., Maeland J.G., et al. Insomnia and long sleep duration are risk factors for later work disability. The Hordaland Health Study. J Sleep Res 2009, 18:122-128.
51. Lerner D., Amick B.C., Rogers W.H., Malspeis S., Bungay K., Cynn D. The work limitations questionnaire. Med Care 2001, 39:72-85.
52. Walsh J.K., Krystal A.D., Amato D.A., Rubens R., Caron J., Wessel T.C., et al. Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations. Sleep 2007, 30:959-968.
53. Erman M., Guiraud A., Joish V.N., Lerner D. Zolpidem extended-release 12.5 mg associated with improvements in work performance in a 6-month randomized, placebo-controlled trial. Sleep 2008 Oct 1, 31(10):1371-1378.
54. Sivertsen B., Overland S., Neckelmann D., Glozier N., Krokstad S., Pallesen S., et al. The long-term effect of insomnia on work disability: the HUNT-2 historical cohort study. Am J Epidemiol 2006, 163:1018-1024.
55. Nakata A., Ikeda T., Takahashi M., Haratani T., Hojou M., Swanson N.G., et al. The prevalence and correlates of occupational injuries in small-scale manufacturing enterprises. J Occup Health 2006, 48:366-376.
56. Partinen M., Hirvonen K., Hublin C., Halavaara M., Hiltunen H. Effects of after-midnight intake of zolpidem and temazepam on driving ability in women with non-organic insomnia. Sleep Med 2003, 4:553-561.
57. Menzin J., Lang K.M., Levy P., Levy E. A general model of the effects of sleep medications on the risk and cost of motor vehicle accidents and its application to France. Pharmacoeconomics 2001, 19:69-78.
58. Wereyer S., Dilling H. Prevalence and treatment of insomnia in the community: results from the Upper Bavarian field study. Sleep 1991, 14:392-398.
59. Kales J.D., Kales A., Bixler E.O., Soldatos C.R., Cadieux R.J., Cashurba C.J., et al. Biopsychobehavioral correlates of insomnia. Clinical characteristics and behavior correlates. Am J Psychiat 1984, 141:1371-1376.
60. Katz D.A., Mc-Horney C.A. Clinical correlates of insomnia in patients with chronic illness. Arch Intern Med 1998, 159:1099-1107.
61. Katz D.A., McHorney C.A. The relationship between insomnia and health-related quality of life in patients with chronic illness. J Fam Pract 2002, 51:229-235.
62. Dirksen S.R., Epstein D.R. Efficacy of an insomnia intervention on fatigue, mood and quality of life in breast cancer survivors. J Adv Nurs 2008, 61:664-675.
63. Novak M., Mucsi I., Shapiro C.M., Rethelyi J., Kopp M.S. Increased utilization of health services by insomniacs - an epidemiological perspective. J Psychosom Res 2004, 56:527-536.
64. National Commission on Sleep Disorders Research Wake up America: a national sleep alert 1993, vol. 1. Executive Summary and Executive Report of National Commission of Sleep Disorders Research, U.S. Government Printing Office, Washington, DC.
65. Leger D. The cost of sleep related accidents: a report for the national commission of sleep disorders research. Sleep 1994, 17:84-93.
66. Stoller M.K. Economic effects of insomnia. Clinical Therapeutics 1994, 16:263-287.
67. Walsh J.K., Engelhardt C.L. The direct economic costs of insomnia in the United State for 1995. Sleep 1999, 22(Suppl.2):5386. S393.
68. Leger D., Levy E., Paillard M. The direct costs of insomnia in France. Sleep 1999, 22(Suppl. 2):5394-5401.
69. Ozminkowski R.J., Wang S., Walsh J.K. The direct and indirect costs of untreated insomnia in adults in the United States. Sleep 2007, 30:263-273.
70. Daley M., Morin C.M., LeBlanc M., Grégoire J.P., Savard J. The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers. Sleep 2009, 32:55-64.
71. Godet-Cayré V., Pelletier-Fleury N., Le Vaillant M., Dinet J., Massuel M.A., Léger D. Insomnia and absenteeism at work. Who pays the cost?. Sleep 2006, 29:179-184.
72. Smith I.E., Shneerson J.M. Is the SF-36 sensitive to sleep disruption? A study in subjects with sleep apnoea. J. Sleep Res 1995, 4:183-188.
73. Zammitt G.K., Weiner J., Damato N., Sillup J.P., McMillan C.A. Quality of life in people with insomnia. Sleep 1999, 22:S379-S385.
74. Leger D., Scheuermaier K., Philip P., Paillard M., Guilleminault C. SF-36: evaluation of quality of life in severe and mild insomniacs compared with good sleepers. Psychosom Med 2001, 63:49-55.
75. Schubert C.R., Cruickshanks K.J., Dalton D.S., Klein B.E., Klein R., Nondahl D.M. Prevalence of sleep problems and quality of life in an older population. Sleep 2002, 25:889-893.
76. Idzikowski C. Impact of insomnia on health-related quality of life. PharmacoEconomics 1996, 10(Suppl. 1):15-24.
77. Russel I.T. The SF-36 health survey questionnaire: an outcome measure suitable for routine use in the NHS. Br Med J 1993, 306:1440-1444.
78. Gureje O., Kola L., Ademola A., Olley B.O. Profile, comorbidity and impact of insomnia in the Ibadan study of ageing. Int J Geriatr Psychiatry 2009, 24:686-693.
79. LeBlanc M., Beaulieu-Bonneau S., Mérette C., Savard J., Ivers H., Morin C.M. Psychological and health-related quality of life factors associated with insomnia in a population-based sample. J Psychosom Res 2007, 63:157-166.
80. Pilowski I., Cettenden I., Townley M. Sleep disturbance in pain clinic patients. Pain 1985, 23:27-33.
81. Stark D., Kiely M., Smith A., Velikova G., House A., Selby P. Anxiety disorders in cancer patients: their nature, associations and quality of life. J Clin Oncol 2002, 20:3137-3148.
82. Lindley C., Vasa S., Sawyer W.T., Winer E.P. Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer. J Clin Oncol 1998, 16:1380-1387.
83. Caap-Ahlgren M., Dehlin O. Insomnia and depressive symptoms in patients with Parkinson disease. Relationship to health-related quality of life. An interview study of patients living at home. Arch Gerontol Geriatr 2001, 32:23-33.
84. Iliescu E.A., Coo H., McMurray M.H., Meers C.L., Quinn M.M., Singer M.A., et al. Quality of sleep and health-related quality of life in haemodialysis patients. Nephrol Dial Transplant 2003, 18:126-132.
85. Molnar M.Z., Novak M., Szeifert L., Ambrus C., Keszei A., Koczy A., et al. Restless legs syndrome, insomnia, and quality of life after renal transplantation. J Psychosom Res 2007, 63:591-597.
86. Krystal A.D., Thakur M., Roth T. Sleep disturbance in psychiatric disorders: effects on function and quality of life in mood disorders, alcoholism, and schizophrenia. Ann Clin Psychiatry 2008, 20:39-46.
87. Nokes K.M., Kendrew J. Correlates of sleep quality in persons with HIV disease. J Assoc Nurses AIDS Care 2001, 12:17-22.
88. Molnar M.Z., Novak M., Mucsi I. Sleep disorders and quality of life in renal transplant recipients. Int Urol Nephrol 2009, 41:373-382.
89. Goldenberg F., Hindmarch J., Joyce C.R.B., Le Gal M., Partinen M., Pilate C. Zopiclone, sleep and health related quality of life. Human Psychopharmacol 1994, 9:245-252.
90. Leger D., Janus C., Pellois A., Quera-Salva M.A., Dreyfus J.P. Sleep, morning alertness and quality of life in subjects treated with zopiclone and in good sleepers. Study comparing 167 patients and 381 good sleepers. Eur Psychiatry 1995, 10(Suppl. 3):99-102.
91. Baca E., Estivill E., Hernandez B., Lopez J.S., on behalf of Castivil group Quality of life in insomnia: influence of zolpidem. J Sleep Res 2002, 11(Suppl. 1):10.
92. Quesnel C., Savard J., Simard S., Ivers H., Morin C. Efficacy of cognitive-behavioral therapy for insomnia in women treated for non metastatic breast cancer. J Consult Clin Psychol 2003, 71:189-200.
93. Dixon S., Morgan K., Mathers N., Thompson J., Tomeny M. Impact of cognitive behavior therapy on health-related quality of life among adult hypnotic users with chronic insomnia. Behav Sleep Med 2006, 4:71-84.
94. Espie C.A., Fleming L., Cassidy J., Samuel L., Taylor L.M., White C.A., et al. Randomized controlled clinical effectiveness trial of cognitive behaviour therapy compared with treatment as usual for persistent insomnia in patients with cancer. J Clin Oncol 2008, 26:4651-4658.